Pathology · Anemias (Hemolytic, Microcytic, Macrocytic, Hemoglobinopathies)

A 22-year-old Southeast Asian man has thalassemia intermedia. Hemoglobin electrophoresis shows HbE 65%, HbF 30%, HbA 0%, HbA2 5%. Which genetic compound heterozygosity best explains this phenotype?

  • A HbE/HbE homozygosity
  • B HbE/HbS compound heterozygote
  • C HbE/beta-thalassemia compound heterozygote
  • D Beta-thalassemia major (homozygous beta0)
Correct answer: C. HbE/beta-thalassemia compound heterozygote

Explanation

HbE/beta-thalassemia is the most common cause of thalassemia intermedia/major in Southeast Asia. HbE itself is a beta-chain variant (Glu26Lys) that also creates a splicing mutation, reducing normal beta-globin and producing a mildly unstable hemoglobin. When combined with a beta-thalassemia allele, total beta-globin output is severely reduced, resulting in HbE + HbF + residual HbA2 without HbA. Clinically it ranges from thalassemia intermedia to major depending on the severity of the coexisting beta-thalassemia allele. Homozygous HbE is mild; HbS/HbE produces a sickle-like disorder.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Anemias (Hemolytic, Microcytic, Macrocytic, Hemoglobinopathies) MCQs

See all Anemias (Hemolytic, Microcytic, Macrocytic, Hemoglobinopathies) MCQs →